FORMOSA LABORATORIES INC NO 36 HOPING STREET TAIWAN

Company Introduction: FORMOSA LABORATORIES INC

FORMOSA LABORATORIES INC is a pharmaceutical manufacturing company (factory) based in Taiwan.

Company Profile:

FORMOSA LABORATORIES INC is a leading pharmaceutical manufacturer with a strong focus on research, development, and production of Active Pharmaceutical Ingredients (APIs). Established in 1983, the company has built a reputation for its commitment to quality, innovation, and adherence to international regulatory standards, including cGMP (current Good Manufacturing Practices). Their operations encompass the entire lifecycle of API development, from initial synthesis to commercial-scale production. They serve a global clientele, providing high-quality pharmaceutical raw materials for various therapeutic areas. The company's dedication to scientific excellence and stringent quality control ensures the reliability and efficacy of their products, making them a trusted partner in the global pharmaceutical industry.

Formosa Laboratories Inc. specializes in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs) and specialty chemicals. Their product portfolio primarily includes:

1. Active Pharmaceutical Ingredients (APIs)

The company produces a wide range of generic and proprietary APIs, focusing on therapeutic areas such as:

Oncology (Anti-cancer agents)

Immunosuppressants

Cardiovascular drugs

Gastrointestinal agents

Antiviral agents

Central Nervous System (CNS) drugs

2. Contract Development and Manufacturing Organization (CDMO) Services

Formosa Laboratories provides comprehensive services for pharmaceutical companies, including:

Custom synthesis of complex chemical molecules

Process research and development (PR&D)

Scale-up and pilot plant production

Commercial manufacturing under cGMP standards

Regulatory support and documentation (DMF filing)

3. Specialty Chemicals and Intermediates

The company manufactures high-value chemical intermediates used in the synthesis of complex pharmaceutical compounds, often utilizing advanced technologies such as:

High-potency API (HPAPI) manufacturing

Peptide synthesis

Complex organic synthesis

Chiral chemistry

4. Finished Dosage Forms (FDF)

In addition to APIs, the company has expanded its capabilities to include the development and manufacturing of finished dosage forms, particularly for niche or high-barrier therapeutic markets.